These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29680267)

  • 1. Oxyntomodulin analogue increases energy expenditure via the glucagon receptor.
    Scott R; Minnion J; Tan T; Bloom SR
    Peptides; 2018 Jun; 104():70-77. PubMed ID: 29680267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL; Huang Q; Brown TJ; Drucker DJ
    Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.
    Bagger JI; Holst JJ; Hartmann B; Andersen B; Knop FK; Vilsbøll T
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4541-52. PubMed ID: 26445112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
    Maida A; Lovshin JA; Baggio LL; Drucker DJ
    Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin.
    Kosinski JR; Hubert J; Carrington PE; Chicchi GG; Mu J; Miller C; Cao J; Bianchi E; Pessi A; Sinharoy R; Marsh DJ; Pocai A
    Obesity (Silver Spring); 2012 Aug; 20(8):1566-71. PubMed ID: 22421924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of stability, cellular, glucose-lowering and appetite supressing effects of oxyntomodulin analogues modified at the N-terminus.
    Lynch AM; Pathak N; Flatt YE; Gault VA; O'Harte FP; Irwin N; Flatt PR
    Eur J Pharmacol; 2014 Nov; 743():69-78. PubMed ID: 25246014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral oxyntomodulin reduces food intake and body weight gain in rats.
    Dakin CL; Small CJ; Batterham RL; Neary NM; Cohen MA; Patterson M; Ghatei MA; Bloom SR
    Endocrinology; 2004 Jun; 145(6):2687-95. PubMed ID: 15001546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S3-2, a novel long-lasting oxyntomodulin derivative, exerts improvement on diabesity and renal injury through activating GLP-1 and glucagon receptors.
    Huang P; Meng L; Tan J; Gu X; Huang M; Huang F; Ma R; Wang J
    Life Sci; 2021 Apr; 270():119136. PubMed ID: 33508289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel long-acting oxyntomodulin analogue eliminates diabetes and obesity in mice.
    Ma T; Huo S; Xu B; Li F; Wang P; Liu Y; Lei H
    Eur J Med Chem; 2020 Oct; 203():112496. PubMed ID: 32682196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2.
    Schepp W; Dehne K; Riedel T; Schmidtler J; Schaffer K; Classen M
    Digestion; 1996; 57(6):398-405. PubMed ID: 8913701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of oxyntomodulin and GLP-1 on glucose metabolism.
    Du X; Kosinski JR; Lao J; Shen X; Petrov A; Chicchi GG; Eiermann GJ; Pocai A
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E265-71. PubMed ID: 22621866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties.
    Bhat VK; Kerr BD; Flatt PR; Gault VA
    Biochem Pharmacol; 2013 Jun; 85(11):1655-62. PubMed ID: 23518155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor.
    Sowden GL; Drucker DJ; Weinshenker D; Swoap SJ
    Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R962-70. PubMed ID: 17038440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxyntomodulin reduces expression of glucagon-like peptide 1 receptor in the brainstem of chickens.
    Moghaddam AG; Yaghoobi MM; Jonaidi H; Mahani MT; Sepehri H
    J Anim Physiol Anim Nutr (Berl); 2010 Aug; 94(4):422-8. PubMed ID: 19663977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glucagon-like peptide 1 and oxyntomodulin on neuronal activity of ghrelin-sensitive neurons in the hypothalamic arcuate nucleus.
    Riediger T; Eisele N; Scheel C; Lutz TA
    Am J Physiol Regul Integr Comp Physiol; 2010 Apr; 298(4):R1061-7. PubMed ID: 20147608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and characterization of novel oxyntomodulin derivatives with potent dual GLP-1/glucagon receptor activation and prolonged antidiabetic effects.
    Pei Z; Zhou D; Yan J; Wang S; Yang X; Pei Z
    Life Sci; 2020 Jul; 253():117651. PubMed ID: 32304764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and pathophysiological aspects of incretin hormones and glucagon.
    Bagger JI
    Dan Med J; 2017 Jan; 64(1):. PubMed ID: 28007055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass.
    Abegg K; Schiesser M; Lutz TA; Bueter M
    Physiol Behav; 2013 Sep; 121():70-8. PubMed ID: 23562866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OXM-104, a potential candidate for the treatment of obesity, NASH and type 2 diabetes.
    Melander SA; Kayed A; Andreassen KV; Karsdal MA; Henriksen K
    Eur J Pharmacol; 2024 Jan; 962():176215. PubMed ID: 38056618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity.
    Zhihong Y; Chen W; Qianqian Z; Lidan S; Qiang Z; Jing H; Wenxi W; Bhawal R
    Peptides; 2023 Apr; 162():170955. PubMed ID: 36669563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.